ADaM Services for Clinical Trials
What is ADaM in Clinical Trials?
ADaM is a CDISC standard used to efficiently generate, replicate, and review clinical trial statistical analyses. ADaM allows traceability among analysis results and data represented in the SDTM standard. Sponsors planning to submit clinical trial data to the FDA of the United States or the PMDA of Japan will need to meet the ADaM standard.
Sofpromed’s CDISC Services
Sofpromed is a biometrics CRO with extensive experience in providing CDISC services for clinical trial sponsors around the world. Our CDISC capabilities include the application of CDASH, SDTM and ADaM standards in phase I-IV clinical trials. Sofpromed’s CDISC services are provided to pharma and biotech companies conducting clinical trials with drugs and medical devices in oncology, cardiovascular, metabolic, central nervous system, dermatology, infectious, and respiratory diseases, among other therapeutic areas.